Starling Oncology annual debt-to-equity ratio
2020
2021
2022
2023
2024
Starling Oncology Debt-to-Equity Ratio Growth & History (STLN)
Starling Oncology's debt-to-equity ratio was 34.34 for fiscal 2024.
View full Starling Oncology company overviewStarling Oncology annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | 34.34 | 32.24 | +1534.47% |
| 2023 | 2023-12-31 | 2.10 | 1.22 | +138.70% |
| 2022 | 2022-12-31 | 0.88 | 0.88 | +32760.90% |
| 2021 | 2021-12-31 | 0.00 | −0.43 | −99.38% |
| 2020 | 2020-12-31 | 0.43 | — | — |
Starling Oncology quarterly debt-to-equity ratio
Q4.20
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2025 | 2025-03-31 | 20.20 | 17.30 | +595.37% |
| Q4 2024 | 2024-12-31 | 34.34 | 32.24 | +1534.47% |
| Q3 2024 | 2024-09-30 | 7.95 | 6.31 | +386.07% |
| Q2 2024 | 2024-06-30 | 4.15 | 2.77 | +201.62% |
| Q1 2024 | 2024-03-31 | 2.91 | 1.78 | +159.28% |
| Q4 2023 | 2023-12-31 | 2.10 | 1.22 | +138.70% |
| Q3 2023 | 2023-09-30 | 1.64 | 0.80 | +96.77% |
| Q2 2023 | 2023-06-30 | 1.38 | 1.22 | +787.41% |
| Q1 2023 | 2023-03-31 | 1.12 | 0.98 | +686.26% |
| Q4 2022 | 2022-12-31 | 0.88 | 0.88 | +32760.90% |
| Q3 2022 | 2022-09-30 | 0.83 | — | — |
| Q2 2022 | 2022-06-30 | 0.15 | — | — |
| Q1 2022 | 2022-03-31 | 0.14 | — | — |
| Q4 2021 | 2021-12-31 | 0.00 | −0.43 | −99.38% |
| Q4 2020 | 2020-12-31 | 0.43 | — | — |
Starling Oncology debt-to-equity ratio trends
Between the periods ended 2020-12-31 and 2024-12-31, Starling Oncology's debt-to-equity ratio increased from 0.43 to 34.34, a change of 33.91. The latest reported quarter, Q1 2025, shows 20.20.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Starling Oncology source filings ↗